$1.85
0.116.32%
Last update: Nov 11, 7:47 PM
TherapeuticsMD Inc
TXMDNASDAQ
TherapeuticsMD rose 10.1% from $1.68 to $1.85, behind the S&P 500's +11.2%. Its worst day was Nov 17 (−22.4%), and its low came Nov 17 at $1.52.
Nov 12, 2025 – Nov 11, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
EPS of $0.00 was reported on $784,000.00 revenue.
−3.6% · S&P 500 −1.7%
TherapeuticsMD shares rose 13.3%, while the S&P 500 rose 0.6%.
Story events cover the past 12 months · Times ET
+13.3%, on 412K shares, the year's heaviest volume · S&P 500 +0.6%
TherapeuticsMD closed at its highest level of the year, 64.9% above where the year started.
+6.1% · S&P 500 +0.5%
EPS of $-0.06 was reported on $893,000.00 revenue.
+1.5% · S&P 500 +2.9%
EPS of $0.01 was reported on $724,000.00 revenue.
+3.6% · S&P 500 +0.6%
TherapeuticsMD shares rose 20.9%, while the S&P 500 rose 0.5%.
+20.9% · S&P 500 +0.5%
EPS of $0.01 was reported on $869,000.00 revenue.
+0.5% · S&P 500 +0.3%
Where it ended: a close of $1.85 on Nov 11, 2026. Up next: Q3 2026 earnings on Nov 24, 2026.
Nothing in the past 12 months.
All TXMD analyst actionsNothing in the past 12 months.
All TXMD dividend historyChart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for TXMD and SPY from Benzinga historical bars. Not investment advice.
